Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IRI, formerly SymphonyIRI Group and originally Information Resources, was a U.S.-based market research and analytics company serving consumer packaged goods, retail, and healthcare customers. In healthcare, the company was known for data, analytics, and market intelligence offerings rather than for developing therapeutics. The name "SymphonyIRI" refers to a historical branding period in which IRI aligned its identity with parent Symphony Technology Group before later returning to the IRI name. In August 2022, IRI merged with The NPD Group, and in March 2023 the combined company rebranded as Circana. Accordingly, Symphony IRI should be treated as a legacy commercial analytics company, not a biotech or pharmaceutical drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IRI.